Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Atte Meretoja

Dados Biográficos

ID10433728
NOMEAtte Meretoja
PRENOMESAtte
SOBRENOMEMeretoja
ASSINATURAMERETOJA A
ORCID0000-0001-6433-1931
VERIFICADONão
TOTAL DE OBRAS49
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR49
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2014
ANO MAIS RECENTE DE PUBLICAÇÃO2024
ÍNDICE H0
  • Burden of disease scenarios for 204 countries and territories, 2022–2050

    Open Access•Stein Emil Vollset, Hazim S Ababneh et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Future trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and prioritisation. We have expanded and improved upon previous forecasts produced as part of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) and provide a reference forecast (the most likely future), and alternativ…

  • Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021

    Open Access•Michael Brauer, Gregory A Roth et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 ri…

  • Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100

    Open Access•Natalia V Bhattacharjee, Austin E Schumacher et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Accurate assessments of current and future fertility-including overall trends and changing population age structures across countries and regions-are essential to help plan for the profound social, economic, environmental, and geopolitical challenges that these changes will bring. Estimates and projections of fertility are necessary to inform policies involving resource and health-care needs, labour supply, education, gender equality,…

  • Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021

    Open Access•Mohsen Naghavi, Kanyin Liane Ong et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mort…

  • Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the Covid-19 pandemic

    Open Access•Austin E Schumacher, Hmwe Hmwe Kyu et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Estimates of demographic metrics are crucial to assess levels and trends of population health outcomes. The profound impact of the COVID-19 pandemic on populations worldwide has underscored the need for timely estimates to understand this unprecedented event within the context of long-term population health trends. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 provides new demographic estimates for 204 cou…

  • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (Dalys), and healthy life expectancy (Hale) for 371 diseases and injuries in 204 countries and territor…

    Open Access•Alize J Ferrari, Damian Francesco Santomauro et al.•ARTICLE•The Lancet•2024

    BACKGROUND: Detailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden over time and across age groups, sexes, and locations. The availability of disease burden estimates can promote evidence-based interventions that enable public health researchers, policy makers, and other professionals to im…

  • Global, regional, and national burden of disorders affecting the nervous system, 1990–2021

    Open Access•Jaimie D Steinmetz, Katrin Seeher et al.•ARTICLE•The Lancet Neurology•2024

    BACKGROUND: Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by…

  • The state of health in the European Union (EU-27) in 2019

    Open Access•João Vasco Santos, Alicia Padron-Monedero et al.•ARTICLE•BMC Public Health•2024

    There was a clear trend towards improvement in the overall health status of the EU but with differences between countries. EU health policymakers need to address the burden of diseases, paying specific attention to causes such as mental disorders. There are many opportunities for mutual learning among otherwise similar countries with different patterns of disease

  • Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050

    Open Access•Emma Nichols, Jaimie D Steinmetz et al.•ARTICLE•The Lancet Public Health•2022

    BACKGROUND: Given the projected trends in population ageing and population growth, the number of people with dementia is expected to increase. In addition, strong evidence has emerged supporting the importance of potentially modifiable risk factors for dementia. Characterising the distribution and magnitude of anticipated growth is crucial for public health planning and resource prioritisation. This study aimed to improve on previous forecasts of…

  • Population-level risks of alcohol consumption by amount, geography, age, sex, and year

    Open Access•Dana Bryazka, Marissa B Reitsma et al.•ARTICLE•The Lancet•2022

    BACKGROUND: The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. METHODS: For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to esti…

  • Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health

    Open Access•Katherine R Paulson, Katherine Paulson et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Sustainable Development Goal 3.2 has targeted elimination of preventable child mortality, reduction of neonatal death to less than 12 per 1000 livebirths, and reduction of death of children younger than 5 years to less than 25 per 1000 livebirths, for each country by 2030. To understand current rates, recent trends, and potential trajectories of child mortality for the next decade, we present the Global Burden of Diseases, Injuries, a…

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019

    Open Access•Marissa B Reitsma, Parkes J Kendrick et al.•ARTICLE•The Lancet•2021

    BACKGROUND: Ending the global tobacco epidemic is a defining challenge in global health. Timely and comprehensive estimates of the prevalence of smoking tobacco use and attributable disease burden are needed to guide tobacco control efforts nationally and globally. METHODS: We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019 as part of the Global B…

  • Global, regional, and national burden of stroke and its risk factors, 1990–2019

    Open Access•Valery L Feigin, Benjamin A Stark et al.•ARTICLE•The Lancet Neurology•2021

    BACKGROUND: Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national leve…

  • Global age-sex-specific fertility, mortality, healthy life expectancy (Hale), and population estimates in 204 countries and territories, 1950–2019

    Open Access•Haidong Wang, Kaja Abbas et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Accurate and up-to-date assessment of demographic metrics is crucial for understanding a wide range of social, economic, and public health issues that affect populations worldwide. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected sub…

  • Five insights from the Global Burden of Disease Study 2019

    Open Access•Christopher J L Murray, Cristiana Abbafati et al.•ARTICLE•The Lancet•2020

  • Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

    Open Access•Gregory A Roth, George A Mensah et al.•ARTICLE•Journal of the American College…•2020

    Cardiovascular diseases (CVDs), principally ischemic heart disease (IHD) and stroke, are the leading cause of global mortality and a major contributor to disability. This paper reviews the magnitude of total CVD burden, including 13 underlying causes of cardiovascular death and 9 related risk factors, using estimates from the Global Burden of Disease (GBD) Study 2019. GBD, an ongoing multinational collaboration to provide comparable and consisten…

  • Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Achieving universal health coverage (UHC) involves all people receiving the health services they need, of high quality, without experiencing financial hardship. Making progress towards UHC is a policy priority for both countries and global institutions, as highlighted by the agenda of the UN Sustainable Development Goals (SDGs) and WHO's Thirteenth General Programme of Work (GPW13). Measuring effective coverage at the health-system le…

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019

    Open Access•Christopher J L Murray, Aleksandr Y Aravkin et al.•ARTICLE•The Lancet•2020

    BACKGROUND: Rigorous analysis of levels and trends in exposure to leading risk factors and quantification of their effect on human health are important to identify where public health is making progress and in which cases current efforts are inadequate. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a standardised and comprehensive assessment of the magnitude of risk factor exposure, relative risk, and attribu…

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019

    Open Access•Theo Vos, Stephen S Lim et al.•ARTICLE•The Lancet•2020

    BACKGROUND: In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive…

  • Global, regional, and national burden of neurological disorders, 1990–2016

    Open Access•Valery L Feigin, Emma Nichols et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is to provide the most comprehensive and up-to-date estimates of the global, regional, and national burden from neurological disorders. METHODS: We estimated prevalence, incidence, deaths, and disability-adjusted life-years (DALYs;…

  • Past, present, and future of global health financing

    Open Access•Alenda Y Chang, Angela Y Chang et al.•ARTICLE•The Lancet•2019

    BACKGROUND: Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from developme…

  • Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016

    Open Access•Emma Nichols, Cassandra Szoeke et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: The number of individuals living with dementia is increasing, negatively affecting families, communities, and health-care systems around the world. A successful response to these challenges requires an accurate understanding of the dementia disease burden. We aimed to present the first detailed analysis of the global prevalence, mortality, and overall burden of dementia as captured by the Global Burden of Diseases, Injuries, and Risk …

  • Global, regional, and national burden of stroke, 1990–2016

    Open Access•Catherine Owens Johnson, Minh Nguyen et al.•ARTICLE•The Lancet Neurology•2019

    BACKGROUND: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including strok…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open Access•Gregory A Roth, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

Próximo

Sem obras proeminentes nesta página.

  • Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990–2013

    Open Access•Haidong Wang, Chelsea A Liddell et al.•ARTICLE•The Lancet•2014

    BACKGROUND: Remarkable financial and political efforts have been focused on the reduction of child mortality during the past few decades. Timely measurements of levels and trends in under-5 mortality are important to assess progress towards the Millennium Development Goal 4 (MDG 4) target of reduction of child mortality by two thirds from 1990 to 2015, and to identify models of success. METHODS: We generated updated estimates of child mortality i…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013

    Open Access•Mohammad H Forouzanfar, Lily Alexander et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013

    Open Access•Christopher J L Murray, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013

    Open Access•Theo Vos, Ryan M Barber et al.•ARTICLE•The Lancet•2015

  • Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015

    Open Access•Haidong Wang, Zulfiqar A Bhutta et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, financial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 …

  • Global, regional, and national disability-adjusted life-years (Dalys) for 315 diseases and injuries and healthy life expectancy (Hale), 1990–2015

    Open Access•Nicholas J Kassebaum, Megha Arora et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Healthy life expectancy (HALE) and disability-adjusted life-years (DALYs) provide summary measures of health across geographies and time that can inform assessments of epidemiological patterns and health system performance, help to prioritise investments in research and development, and monitor progress toward the Sustainable Development Goals (SDGs). We aimed to provide updated HALE and DALYs for geographies worldwide and evaluate ho…

  • Global, regional, and national levels of maternal mortality, 1990–2015

    Open Access•Nicholas J Kassebaum, Ryan M Barber et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In transitioning from the Millennium Development Goal to the Sustainable Development Goal era, it is imperative to comprehensively assess progress toward reducing maternal mortality to identify areas of success, remaining challenges, and frame policy discussions. We aimed to quantify maternal mortality throughout the world by underlying cause and age from 1990 to 2015. METHODS: We estimated maternal mortality at the global, regional, …

  • Measuring the health-related Sustainable Development Goals in 188 countries

    Open Access•Stephen S Lim, Kate Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: In September, 2015, the UN General Assembly established the Sustainable Development Goals (SDGs). The SDGs specify 17 universal goals, 169 targets, and 230 indicators leading up to 2030. We provide an analysis of 33 health-related SDG indicators based on the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015). METHODS: We applied statistical methods to systematically compiled data to estimate the performance of…

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015

    Open Access•Haidong Wang, Mohsen Naghavi et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns bas…

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015

    Open Access•Mohammad H Forouzanfar, Ashkan Afshin et al.•ARTICLE•The Lancet•2016

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden of disease. By providing national and subnational assessments spanning the past 25 years, this study can inform debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework developed for previous iterations of t…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015

    Open Access•Theo Vos, Christine Allen et al.•ARTICLE•The Lancet•2016

    BACKGROUND: Non-fatal outcomes of disease and injury increasingly detract from the ability of the world's population to live in full health, a trend largely attributable to an epidemiological transition in many countries from causes affecting children, to non-communicable diseases (NCDs) more common in adults. For the Global Burden of Diseases, Injuries, and Risk Factors Study 2015 (GBD 2015), we estimated the incidence, prevalence, and years liv…

  • Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries

    Open Access•Nancy Fullman, Ryan M Barber et al.•ARTICLE•The Lancet•2017

    BACKGROUND: The UN's Sustainable Development Goals (SDGs) are grounded in the global ambition of "leaving no one behind". Understanding today's gains and gaps for the health-related SDGs is essential for decision makers as they aim to improve the health of populations. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016), we measured 37 of the 50 health-related SDG indicators over the period 1990-2016 for 188…

  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016

    Open Access•Theo Vos, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: As mortality rates decline, life expectancy increases, and populations age, non-fatal outcomes of diseases and injuries are becoming a larger component of the global burden of disease. The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of prevalence, incidence, and years lived with disability (YLDs) for 328 causes in 195 countries and territories from 1990 to 2016. METHO…

  • Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015

    Open Access•Ryan M Barber, Nancy Fullman et al.•ARTICLE•The Lancet•2017

    BACKGROUND: National levels of personal health-care access and quality can be approximated by measuring mortality rates from causes that should not be fatal in the presence of effective medical care (ie, amenable mortality). Previous analyses of mortality amenable to health care only focused on high-income countries and faced several methodological challenges. In the present analysis, we use the highly standardised cause of death and risk factor …

  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016

    Open Access•Mohsen Naghavi, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Monitoring levels and trends in premature mortality is crucial to understanding how societies can address prominent sources of early death. The Global Burden of Disease 2016 Study (GBD 2016) provides a comprehensive assessment of cause-specific mortality for 264 causes in 195 locations from 1980 to 2016. This assessment includes evaluation of the expected epidemiological transition with changes in development and where local patterns …

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016

    Open Access•Emmanuela Gakidou, Ashkan Afshin et al.•ARTICLE•The Lancet•2017

    BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) provides a comprehensive assessment of risk factor exposure and attributable burden of disease. By providing estimates over a long time series, this study can monitor risk exposure trends critical to health surveillance and inform policy debates on the importance of addressing risks in context. METHODS: We used the comparative risk assessment framework dev…

  • Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016

    Open Access•Haidong Wang, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Detailed assessments of mortality patterns, particularly age-specific mortality, represent a crucial input that enables health systems to target interventions to specific populations. Understanding how all-cause mortality has changed with respect to development status can identify exemplars for best practice. To accomplish this, the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) estimated age-specific and …

  • Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015

    Open Access•Gregory A Roth, Catherine Johnson et al.•ARTICLE•Journal of the American College…•2017

    BACKGROUND: The burden of cardiovascular diseases (CVDs) remains unclear in many regions of the world. OBJECTIVES: The GBD (Global Burden of Disease) 2015 study integrated data on disease incidence, prevalence, and mortality to produce consistent, up-to-date estimates for cardiovascular burden. METHODS: CVD mortality was estimated from vital registration and verbal autopsy data. CVD prevalence was estimated using modeling software and data from h…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 333 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2016

    Open Access•Simon I Hay, Amanuel Alemu Abajobir et al.•ARTICLE•The Lancet•2017

    BACKGROUND: Measurement of changes in health across locations is useful to compare and contrast changing epidemiological patterns against health system performance and identify specific needs for resource allocation in research, policy development, and programme decision making. Using the Global Burden of Diseases, Injuries, and Risk Factors Study 2016, we drew from two widely used summary measures to monitor such changes in population health: di…

  • Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017

    Open Access•Daniel Dicker, Grant Nguyen et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Assessments of age-specific mortality and life expectancy have been done by the UN Population Division, Department of Economics and Social Affairs (UNPOP), the United States Census Bureau, WHO, and as part of previous iterations of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD). Previous iterations of the GBD used population estimates from UNPOP, which were not derived in a way that was internally consistent wit…

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017

    Open Access•Gregory A Roth, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD …

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017

    Open Access•Jeffrey D Stanaway, Ashkan Afshin et al.•ARTICLE•The Lancet•2018

    BackgroundThe Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor quantification that offers a useful tool for synthesising evidence on risks and risk–outcome associations. With each annual GBD study, we update the GBD CRA to incorporate improved methods, new risks and risk–outcome pairs, and new data on risk exposure levels and risk–outcome associatio…

  • Global, regional, and national disability-adjusted life-years (Dalys) for 359 diseases and injuries and healthy life expectancy (Hale) for 195 countries and territories, 1990–2017

    Open Access•Hmwe Hmwe Kyu, D Abate et al.•ARTICLE•The Lancet•2018

    BACKGROUND: How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure o…

  • Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations

    Open Access•Nancy Fullman, Jamal A Yearwood et al.•ARTICLE•The Lancet•2018

    BACKGROUND: A key component of achieving universal health coverage is ensuring that all populations have access to quality health care. Examining where gains have occurred or progress has faltered across and within countries is crucial to guiding decisions and strategies for future improvement. We used the Global Burden of Diseases, Injuries, and Risk Factors Study 2016 (GBD 2016) to assess personal health-care access and quality with the Healthc…

  • Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories

    Open Access•R Lozano, Nancy Fullman et al.•ARTICLE•The Lancet•2018

    BACKGROUND: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of "leaving no one behind", it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2…

Medicine (47 obras) · Environmental health (44 obras) · Burden of disease (35 obras) · Disease (31 obras) · Population (28 obras) · Demography (25 obras) · Global Maternal and Child Health (22 obras) · Disease burden (18 obras) · Global health (16 obras) · Life expectancy (16 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae